Injective’s affiliated entity has secured transfer agent registration from the U.S. Securities and Exchange Commission (SEC) for its institutional services division, according to CoinTelegraph. This regulatory approval marks a significant step for Injective as it expands its presence in the institutional financial sector.
The SEC transfer agent registration allows Injective’s institutional arm to handle critical administrative functions related to securities, such as managing shareholder records and facilitating transfers. This move could enhance trust and operational capabilities for Injective in regulated markets.
For Japanese investors and market participants, this development highlights the growing integration of blockchain-based services within traditional regulatory frameworks, signaling potential opportunities for cross-border institutional collaboration in FX, crypto, and equities.